Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer

2 Dec 2021

Abstract excerpt

Blood-based biomarkers including systemic inflammation (SI) indicators or circulating factors (cytokines, chemokines, or growth factors) are associated with a poor prognosis for lung cancer patients. Collectively these biomarkers can predict the immune state of a patient. We wanted to define and compare the immune states of small cell and non-small cell lung cancer patients, in the hopes that the information...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immune Cell Function and Interaction
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34855926
DOI: 10.1371/journal.pone.0260988

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancerPMID 34855926Read ↗

Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma.Semantic proximity Read ↗

Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Inflammation Scores as Prognostic Biomarkers in Small Cell Lung Cancer: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis.Semantic proximity Read ↗

Lung Cancer Subtypes Generate Unique Immune Responses.Semantic proximity Read ↗

IL-6, NLR, and SII Markers and Their Relation with Alterations in CD8+ T-Lymphocyte Subpopulations in Patients Treated for Lung AdenocarcinomaSemantic proximity Read ↗

Phenotypic, functional, and metabolic heterogeneity of immune cells infiltrating non–small cell lung cancerSemantic proximity Read ↗

Differential expression of immune-regulatory proteins C5AR1, CLEC4A and NLRP3 on peripheral blood mononuclear cells in early-stage non-small cell lung cancer patientsSemantic proximity Read ↗

The prognostic values of systemic immune-inflammation index and derived neutrophil-lymphocyte ratio in EGFR-mutant advanced non-small cell lung cancer.Semantic proximity Read ↗

Identification of Immune Subtypes and Candidate mRNA Vaccine Antigens in Small Cell Lung CancerSemantic proximity Read ↗

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio: Side by Side with Molecular Mutations in Patients with Non-small Cell Lung Cancer. The INOLUNG StudySemantic proximity Read ↗

Evaluation of the Immune Response within the Tumor Microenvironment in African American and Non-Hispanic White Patients with Non–Small Cell Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.